Last updated: June 14, 2024
Sponsor: Ahram Canadian University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Thalassemia
Treatment
inspiratory muscle training
Clinical Study ID
NCT06466304
P.T -INT-06/2024- 544
Ages 8-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
40 beta thalassemia major children
boys and girls
Exclusion
Exclusion Criteria:
respiratory diseases
cardiac diseases renal diseases liver diseases muscle and joint disease
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: inspiratory muscle training
Phase:
Study Start date:
June 06, 2024
Estimated Completion Date:
October 01, 2024
Study Description
Connect with a study center
Ahram canadian university
Giza,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.